Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome.

G.G. Schwartz; A.G. Olsson; C.M. Ballantyne; P.J. Barter; I.M. Holme; D. Kallend; L.A. Leiter; E. Leitersdorf; J.J. McMurray; P.K. Shah; J.C. Tardif; B.R. Chaitman; R. Duttlinger-Maddux; P.A.F.M. Doevendans; x dal-OUTCOMES Committees and Investigators; J. Mathieson

Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome.

Translated title of the contribution: Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome.

G.G. Schwartz
, A.G. Olsson
, C.M. Ballantyne
, P.J. Barter
, I.M. Holme
, D. Kallend
, L.A. Leiter
, E. Leitersdorf
, J.J. McMurray
, P.K. Shah
, J.C. Tardif
, B.R. Chaitman
, R. Duttlinger-Maddux
, P.A.F.M. Doevendans
, x dal-OUTCOMES Committees and Investigators
, J. Mathieson

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome.
Original language	Undefined/Unknown
Pages (from-to)	896-u34
Number of pages	863
Journal	American Heart Journal
Volume	158
Issue number	6
Publication status	Published - 2009

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed/19958854

Cite this

Schwartz, G. G., Olsson, A. G., Ballantyne, C. M., Barter, P. J., Holme, I. M., Kallend, D., Leiter, L. A., Leitersdorf, E., McMurray, J. J., Shah, P. K., Tardif, J. C., Chaitman, B. R., Duttlinger-Maddux, R., Doevendans, P. A. F. M., dal-OUTCOMES Committees and Investigators, X., & Mathieson, J. (2009). Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome. American Heart Journal, 158(6), 896-u34. http://www.ncbi.nlm.nih.gov/pubmed/19958854

@article{d3c8151e75134c2bb8c643fb101df75e,

title = "Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome.",

author = "G.G. Schwartz and A.G. Olsson and C.M. Ballantyne and P.J. Barter and I.M. Holme and D. Kallend and L.A. Leiter and E. Leitersdorf and J.J. McMurray and P.K. Shah and J.C. Tardif and B.R. Chaitman and R. Duttlinger-Maddux and P.A.F.M. Doevendans and \{dal-OUTCOMES Committees and Investigators\}, x and J. Mathieson",

year = "2009",

language = "Undefined/Unknown",

volume = "158",

pages = "896--u34",

journal = "American Heart Journal",

issn = "0002-8703",

publisher = "Elsevier",

number = "6",

}

Schwartz, GG, Olsson, AG, Ballantyne, CM, Barter, PJ, Holme, IM, Kallend, D, Leiter, LA, Leitersdorf, E, McMurray, JJ, Shah, PK, Tardif, JC, Chaitman, BR, Duttlinger-Maddux, R, Doevendans, PAFM, dal-OUTCOMES Committees and Investigators, X & Mathieson, J 2009, 'Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome.', American Heart Journal, vol. 158, no. 6, pp. 896-u34. <http://www.ncbi.nlm.nih.gov/pubmed/19958854>

TY - JOUR

T1 - Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome.

AU - Schwartz, G.G.

AU - Olsson, A.G.

AU - Ballantyne, C.M.

AU - Barter, P.J.

AU - Holme, I.M.

AU - Kallend, D.

AU - Leiter, L.A.

AU - Leitersdorf, E.

AU - McMurray, J.J.

AU - Shah, P.K.

AU - Tardif, J.C.

AU - Chaitman, B.R.

AU - Duttlinger-Maddux, R.

AU - Doevendans, P.A.F.M.

AU - dal-OUTCOMES Committees and Investigators, x

AU - Mathieson, J.

PY - 2009

Y1 - 2009

M3 - Article

SN - 0002-8703

VL - 158

SP - 896-u34

JO - American Heart Journal

JF - American Heart Journal

IS - 6

ER -